GC
EDIT icon

Guggenheim Capital’s Editas Medicine EDIT Stock Holding History

Guggenheim Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,112
Closed -$578K – 1943
2022
Q4 		$578K Buy
65,112
+15,113
+30% +$166K 0.01% 1416
2022
Q3 		$612K Sell
49,999
-13,400
-21% -$209K 0.01% 1386
2022
Q2 		$750K Buy
63,399
+8,739
+16% +$117K 0.01% 1369
2022
Q1 		$1.04M Buy
54,660
+11,891
+28% +$221K 0.01% 1343
2021
Q4 		$1.14M Buy
42,769
+13,628
+47% +$469K 0.01% 1305
2021
Q3 		$1.2M Sell
29,141
-10,552
-27% -$578K 0.01% 1331
2021
Q2 		$2.25M Buy
39,693
+2,524
+7% +$93.2K 0.01% 1032
2021
Q1 		$1.56M Buy
+37,169
New +$2.12M 0.01% 1163
2018
Q4 		– Sell
-71,863
Closed -$2.29M – 2218
2018
Q3 		$2.29M Buy
71,863
+4,827
+7% +$156K 0.01% 1168
2018
Q2 		$2.4M Buy
67,036
+11,154
+20% +$395K 0.02% 1140
2018
Q1 		$1.85M Sell
55,882
-19,598
-26% -$698K ﹤0.01% 1693
2017
Q4 		$2.32M Buy
+75,480
New +$1.9M 0.01% 1551

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Guggenheim Capital's EDIT Position: Q1 2023 in Review

Guggenheim Capital sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 65,112 shares — an estimated $578K sold.

Guggenheim Capital first reported a position in EDIT in Q4 2017 and held it in 12 quarters. The position peaked at $2.4M in Q2 2018. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Guggenheim Capital reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Guggenheim Capital sold 65,112 Editas Medicine shares in Q1 2023, an estimated $578K.
  • Guggenheim Capital first reported a position in Editas Medicine in Q4 2017 and held it in 12 quarters.
  • Guggenheim Capital's Editas Medicine position peaked at $2.4M in Q2 2018.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.